Kshivets IASLC 2019

Oleg Kshivets
Oleg Kshivetsthoracic/abdominal/general surgeon & surgical oncologist at Siauliai Public Hospital
Early Detection of Lung
Cancer: Optimal Strategies
Oleg Kshivets, MD, PhD Surgery Department, Roshal Hospital, Roshal, Moscow, Russia
Objective: Significance of blood cell subpopulations in terms of early detection of lung cancer
(LC) was investigated.
Methods: In trial (1987-2019) consecutive cases after surgery, monitored 115 LC patients (LCP)
(m=100, f=15; lobectomies=115) with pathologic stage IA (tumor size=1.86±0.30 cm;
squamous=51, adenocarcinoma=59, large cell=5; T1N0M0=115; G1=39, G2=42, G3=34, 5-year
survival=100%) and control group (CG) (n=402): 120 healthy donors (HD) (m=69, f=51) and 282
patients with lung non-malignant pathology (NMP) (m=188, f=94; pneumonectomies=5,
lobectomies=179, segmentectomies=98; non-malignant tumors=100; abscess=112;
tuberculoma=70) were reviewed. Variables selected for study were input levels of blood cell
circuit, sex, age, TNMG. Differences between groups were evaluated using discriminant
analysis, clustering, nonlinear estimation, structural equation modeling, Monte Carlo, bootstrap
simulation and neural networks computing.
Results: It was revealed that early detection of LC from CG (n=517) significantly depended on:
leucocytes (abs, total), segmented neutrophils (%, abs, total), lymphocytes (%), monocytes (%,
abs, total) (P=0.048-0.000). Neural networks computing, genetic algorithm selection and
bootstrap simulation revealed relationships of early detection of LC and lymphocytes (rank=1),
segmented neutrophils (rank=2), monocytes (3), eosinophils (4), leucocytes (5), stick neutrophils
(6). Correct recognition of early LCP from CG was 100% by neural networks computing
(error=0.000; area under ROC curve=1.0).
Conclusion: Early detection of LC from HD and NMP significantly depended on blood cell
subpopulations.
Blood
Factors
Mean
NMP+Norm
Mean
Cancer
t-value p Std.Dev.
NMP+Norm
Std.Dev.
Cancer
Leucocytes 5.32015 5.87043 -2.71185 0.006915 1.78399 2.33204
Stick Neutrophils 0.99502 1.09565 -0.64469 0.519414 1.50973 1.35059
Segmented Neutrophils 58.39055 61.46087 -2.53241 0.011624 11.55100 11.15622
Eosinophils 3.56219 3.05617 1.37675 0.169188 3.71119 2.47445
Monocytes 2.94527 3.46087 -1.97725 0.048546 2.32024 2.92085
Lymphocytes 34.19403 30.94783 2.75936 0.005998 11.23262 10.73594
Eosinophils abs 0.18837 0.17902 0.43436 0.664208 0.21370 0.16201
Stick Neutrophils abs 0.05749 0.07092 -1.09385 0.274532 0.11302 0.12631
Segmented Neutrophils abs 3.14426 3.60482 -3.10649 0.001998 1.36638 1.52038
Lymphocytes abs 1.77649 1.80523 -0.30561 0.760026 0.77289 1.21320
Monocytes abs 0.15535 0.21188 -3.36648 0.000818 0.13944 0.21328
Eosinophils tot 0.91769 0.86378 0.51673 0.605569 1.03943 0.77206
Stick Neutrophils tot 0.27943 0.35086 -1.22613 0.220709 0.52941 0.62059
Segmented Neutrophils tot 15.30056 17.73777 -3.16338 0.001652 7.03675 8.09992
Lymphocytes tot 8.62168 8.80075 -0.37016 0.711413 4.09357 5.96624
Monocytes tot 0.75284 1.04564 -3.55172 0.000418 0.68479 1.04679
Leucocytes tot 25.85628 28.79386 -2.68146 0.007565 9.74573 12.27662
Blood Factors
N=517
Discriminant Function Analysis Summary (elc_dp_n002)
No. of vars in model: 17; Grouping: Ca_NMP (2 grps) Wilks'
Lambda: .93942 approx. F (17,499)=1.8928 p< .0166
Wilks'
Lambda
Partial
Lambda
F-remove
(1,499)
p-value Toler.
1-Toler.
(R-Sqr.)
Leucocytes 0.945636 0.993430 3.299895 0.069884 0.000030 0.999970
Stick Neutrophils 0.941472 0.997824 1.088048 0.297409 0.108486 0.891514
Segmented Neutrophils 0.941266 0.998043 0.978654 0.323011 0.004721 0.995279
Eosinophils 0.944501 0.994624 2.697189 0.101155 0.031829 0.968171
Monocytes 0.944698 0.994417 2.801764 0.094787 0.048493 0.951507
Lymphocytes 0.942826 0.996391 1.807346 0.179438 0.004708 0.995292
Eosinophils abs 0.948309 0.990630 4.719812 0.030287 0.002269 0.997731
Stick Neutrophils abs 0.944118 0.995028 2.493570 0.114946 0.004633 0.995367
Segmented Neutrophils abs 0.945233 0.993854 3.085688 0.079597 0.000056 0.999944
Lymphocytes abs 0.946093 0.992951 3.542417 0.060400 0.000137 0.999864
Monocytes abs 0.944160 0.994983 2.515877 0.113338 0.003474 0.996526
Eosinophils tot 0.947924 0.991032 4.515480 0.034080 0.002778 0.997222
Stick Neutrophils tot 0.943604 0.995569 2.220710 0.136802 0.005169 0.994831
Segmented Neutrophils tot 0.945435 0.993641 3.193357 0.074545 0.000057 0.999943
Lymphocytes tot 0.946065 0.992980 3.527546 0.060940 0.000143 0.999857
Monocytes tot 0.941900 0.997370 1.315639 0.251926 0.003925 0.996075
Leucocytes tot 0.945715 0.993347 3.341892 0.068134 0.000028 0.999972
Effect
All Groups Ca—NMP+Norm - Test of all
effects Distribution : BINOMIAL, Link
function: LOGIT Modeled probability
that Ca—NMP+Norm=Ca
Degr. of
Freedom
Wald
Stat.
p
Intercept 1 2.770466 0.096018
Leucocytes 1 4.424666 0.035423
Stick Neutrophils 1 2.169120 0.140807
Segmented Neutrophils 1 2.539519 0.111029
Eosinophils 1 5.206370 0.022504
Monocytes 1 3.465356 0.062667
Lymphocytes 1 3.564749 0.059019
Eosinophils abs 1 5.786612 0.016149
Stick Neutrophils abs 1 4.212904 0.040118
Segmented Neutrophils abs 1 4.277158 0.038628
Lymphocytes abs 1 4.608960 0.031805
Monocytes abs 1 3.934539 0.047304
Eosinophils tot 1 5.587765 0.018086
Stik Neutrophils tot 1 4.061129 0.043881
Segmented Neutrophils tot 1 4.379579 0.036372
Lymphocytes tot 1 4.621466 0.031574
Monocytes tot 1 3.281245 0.070076
Leucocytes tot 1 4.482998 0.034234
Neural Networks: n=517;
Baseline Error=0.000;
Area under ROC Curve=1.000;
Correct Classification Rate=100%
Rank Sensitivity
Lymphocytes 1 211222
Segmented Neutrophils 2 16605
Monocytes 3 11174
Eosinophils 4 9421
Leucocytes 5 9065
Stick Neutrophils 6 8777
Bootstrap Simulation
Significant Factors
(Number of Samples=3333)
Rank Kendall’Tau-A P<
Segmented Neutrophils abs 1 -0.075 0.05
Segmented Neutrophils tot 2 -0.069 0.05
Lymphocytes 3 0.063 0.05
Leucocytes tot 4 -0.059 0.05
P132
1 of 1

Recommended

Kshivets iaslc toronto2018 by
Kshivets iaslc toronto2018Kshivets iaslc toronto2018
Kshivets iaslc toronto2018Oleg Kshivets
10.8K views1 slide
Kshivets O. Lung Cancer Surgery by
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryOleg Kshivets
1.8K views71 slides
Kshivets IASLC_Vienna2016 by
Kshivets IASLC_Vienna2016Kshivets IASLC_Vienna2016
Kshivets IASLC_Vienna2016Oleg Kshivets
7.6K views1 slide
Kshivets barcelona2016 by
Kshivets barcelona2016Kshivets barcelona2016
Kshivets barcelona2016Oleg Kshivets
5.8K views1 slide
Kshivets aats new_york2019 by
Kshivets aats new_york2019Kshivets aats new_york2019
Kshivets aats new_york2019Oleg Kshivets
29.8K views1 slide
Kshivets wscts2015 by
Kshivets wscts2015Kshivets wscts2015
Kshivets wscts2015Oleg Kshivets
7.4K views20 slides

More Related Content

What's hot

Kshivets wscts2019 sofia by
Kshivets wscts2019 sofiaKshivets wscts2019 sofia
Kshivets wscts2019 sofiaOleg Kshivets
10.9K views16 slides
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery by
Kshivets O.  Esophageal & Cardioesophageal Cancer SurgeryKshivets O.  Esophageal & Cardioesophageal Cancer Surgery
Kshivets O. Esophageal & Cardioesophageal Cancer SurgeryOleg Kshivets
748 views1 slide
Kshivets O. Lung Cancer Surgery by
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryOleg Kshivets
800 views31 slides
Kshivets aats new_york2018 by
Kshivets aats new_york2018Kshivets aats new_york2018
Kshivets aats new_york2018Oleg Kshivets
12.1K views1 slide
Kshivets sso2013 by
Kshivets sso2013Kshivets sso2013
Kshivets sso2013Oleg Kshivets
2K views24 slides
Kshivets O. Lung Cancer Surgery by
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer SurgeryOleg Kshivets
1.1K views22 slides

What's hot(20)

Kshivets wscts2019 sofia by Oleg Kshivets
Kshivets wscts2019 sofiaKshivets wscts2019 sofia
Kshivets wscts2019 sofia
Oleg Kshivets10.9K views
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery by Oleg Kshivets
Kshivets O.  Esophageal & Cardioesophageal Cancer SurgeryKshivets O.  Esophageal & Cardioesophageal Cancer Surgery
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery
Oleg Kshivets748 views
Kshivets O. Lung Cancer Surgery by Oleg Kshivets
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets800 views
Kshivets aats new_york2018 by Oleg Kshivets
Kshivets aats new_york2018Kshivets aats new_york2018
Kshivets aats new_york2018
Oleg Kshivets12.1K views
Kshivets O. Lung Cancer Surgery by Oleg Kshivets
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets1.1K views
Kshivets O. Esophagogastric Cancer Surgery by Oleg Kshivets
Kshivets O. Esophagogastric Cancer SurgeryKshivets O. Esophagogastric Cancer Surgery
Kshivets O. Esophagogastric Cancer Surgery
Oleg Kshivets875 views
Kshivets O. Lung Cancer: Early Detection and Diagnosis by Oleg Kshivets
Kshivets O. Lung Cancer: Early Detection and Diagnosis Kshivets O. Lung Cancer: Early Detection and Diagnosis
Kshivets O. Lung Cancer: Early Detection and Diagnosis
Oleg Kshivets1K views
Kshivets iaslc singapore2020 by Oleg Kshivets
Kshivets iaslc singapore2020Kshivets iaslc singapore2020
Kshivets iaslc singapore2020
Oleg Kshivets29.6K views
Kshivets O. Cardioesophageal Cancer Surgery by Oleg Kshivets
Kshivets O. Cardioesophageal Cancer SurgeryKshivets O. Cardioesophageal Cancer Surgery
Kshivets O. Cardioesophageal Cancer Surgery
Oleg Kshivets1.1K views
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT by Oleg Kshivets
PRECISE EARLY DETECTION OF LUNG  CANCER AND IMMUNE CIRCUITPRECISE EARLY DETECTION OF LUNG  CANCER AND IMMUNE CIRCUIT
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT
Oleg Kshivets13.7K views
Lung Cancer: 10-Year Survival by Oleg Kshivets
Lung Cancer: 10-Year Survival           Lung Cancer: 10-Year Survival
Lung Cancer: 10-Year Survival
Oleg Kshivets40.2K views
Kshivets iaslc denver2021 by Oleg Kshivets
Kshivets iaslc denver2021Kshivets iaslc denver2021
Kshivets iaslc denver2021
Oleg Kshivets3.8K views
Kshivets iaslc denver2015 by Oleg Kshivets
Kshivets iaslc denver2015Kshivets iaslc denver2015
Kshivets iaslc denver2015
Oleg Kshivets8.3K views
Kshivets O. Lung Cancer Surgery by Oleg Kshivets
Kshivets O. Lung Cancer SurgeryKshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets856 views
Kshivets Hong Kong Sydney2020 by Oleg Kshivets
Kshivets Hong Kong Sydney2020Kshivets Hong Kong Sydney2020
Kshivets Hong Kong Sydney2020
Oleg Kshivets27.8K views
Kshivets wscts2018 ljubljana by Oleg Kshivets
Kshivets wscts2018 ljubljanaKshivets wscts2018 ljubljana
Kshivets wscts2018 ljubljana
Oleg Kshivets11.1K views
Kshivets ASCO Chicago2020 by Oleg Kshivets
Kshivets ASCO Chicago2020Kshivets ASCO Chicago2020
Kshivets ASCO Chicago2020
Oleg Kshivets20.1K views
Kshivets barcelona2019 by Oleg Kshivets
Kshivets barcelona2019Kshivets barcelona2019
Kshivets barcelona2019
Oleg Kshivets9.9K views

Similar to Kshivets IASLC 2019

Kshivets yokohama iaslc2017 by
Kshivets yokohama iaslc2017Kshivets yokohama iaslc2017
Kshivets yokohama iaslc2017Oleg Kshivets
4.1K views1 slide
2021 esmo world_gi_poster_kshivets by
2021 esmo world_gi_poster_kshivets2021 esmo world_gi_poster_kshivets
2021 esmo world_gi_poster_kshivetsOleg Kshivets
8.7K views1 slide
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva... by
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...Oleg Kshivets
16.3K views1 slide
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosis by
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosisLiver transplantation vs Resection in cholangiocarcinoma on cirrhosis
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosisEric Vibert, MD, PhD
840 views21 slides
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency... by
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...European School of Oncology
602 views41 slides
Kshivets chicago2016 by
Kshivets chicago2016Kshivets chicago2016
Kshivets chicago2016Oleg Kshivets
6.6K views1 slide

Similar to Kshivets IASLC 2019(19)

Kshivets yokohama iaslc2017 by Oleg Kshivets
Kshivets yokohama iaslc2017Kshivets yokohama iaslc2017
Kshivets yokohama iaslc2017
Oleg Kshivets4.1K views
2021 esmo world_gi_poster_kshivets by Oleg Kshivets
2021 esmo world_gi_poster_kshivets2021 esmo world_gi_poster_kshivets
2021 esmo world_gi_poster_kshivets
Oleg Kshivets8.7K views
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva... by Oleg Kshivets
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...
Oleg Kshivets16.3K views
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosis by Eric Vibert, MD, PhD
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosisLiver transplantation vs Resection in cholangiocarcinoma on cirrhosis
Liver transplantation vs Resection in cholangiocarcinoma on cirrhosis
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency... by European School of Oncology
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
Controversies in Surgical Approach to Breast Cancer by spa718
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancer
spa7181.5K views
Kshivets O. Esophageal and Cardioesophageal Cancer Surgery by Oleg Kshivets
Kshivets O. Esophageal and Cardioesophageal Cancer SurgeryKshivets O. Esophageal and Cardioesophageal Cancer Surgery
Kshivets O. Esophageal and Cardioesophageal Cancer Surgery
Oleg Kshivets1.2K views
Predictors of MDT review and the impact on lung cancer survival for HNELHD re... by Cancer Institute NSW
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Non–Small Cell Lung Cancer by fondas vakalis
Non–Small Cell Lung CancerNon–Small Cell Lung Cancer
Non–Small Cell Lung Cancer
fondas vakalis2.4K views
Kshivets O. Lung Cancer Stage III Surgery by Oleg Kshivets
Kshivets O. Lung Cancer Stage III Surgery Kshivets O. Lung Cancer Stage III Surgery
Kshivets O. Lung Cancer Stage III Surgery
Oleg Kshivets1K views
Haplo-cord transplantation offers similar results compared to MUD transplanta... by cordbloodsymposium
Haplo-cord transplantation offers similar results compared to MUD transplanta...Haplo-cord transplantation offers similar results compared to MUD transplanta...
Haplo-cord transplantation offers similar results compared to MUD transplanta...
cordbloodsymposium1.1K views
Kshivets barcelona2020 by Oleg Kshivets
Kshivets barcelona2020Kshivets barcelona2020
Kshivets barcelona2020
Oleg Kshivets21.8K views
1090716-非小細胞肺癌於精準醫療治療下的診斷與治療 by Ks doctor
1090716-非小細胞肺癌於精準醫療治療下的診斷與治療1090716-非小細胞肺癌於精準醫療治療下的診斷與治療
1090716-非小細胞肺癌於精準醫療治療下的診斷與治療
Ks doctor108 views
Kshivets_SPB_WSCTS2022Lung.pdf by Oleg Kshivets
Kshivets_SPB_WSCTS2022Lung.pdfKshivets_SPB_WSCTS2022Lung.pdf
Kshivets_SPB_WSCTS2022Lung.pdf
Oleg Kshivets275 views
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior... by Oleg Kshivets
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Oleg Kshivets78 views
KshivetsWSCTS2023_Brazil.pdf by Oleg Kshivets
KshivetsWSCTS2023_Brazil.pdfKshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
Oleg Kshivets350 views

More from Oleg Kshivets

Kshivets_IASLC_Singapore2023.pdf by
Kshivets_IASLC_Singapore2023.pdfKshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdfOleg Kshivets
279 views18 slides
Kshivets_WCGIC2023.pdf by
Kshivets_WCGIC2023.pdfKshivets_WCGIC2023.pdf
Kshivets_WCGIC2023.pdfOleg Kshivets
407 views2 slides
Kshivets_SPB_WSCTS2022Eso.pdf by
Kshivets_SPB_WSCTS2022Eso.pdfKshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdfOleg Kshivets
283 views19 slides
Esophageal Cancer: Precise Prediction by
Esophageal Cancer: Precise Prediction      Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction Oleg Kshivets
98 views19 slides
Kshivets gc 10_ys_wjarr-2021-0659 by
Kshivets gc 10_ys_wjarr-2021-0659Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659Oleg Kshivets
4.9K views13 slides
Kshivets lc10 ys_wjarr by
Kshivets lc10 ys_wjarrKshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarrOleg Kshivets
5.8K views15 slides

More from Oleg Kshivets(9)

Kshivets_IASLC_Singapore2023.pdf by Oleg Kshivets
Kshivets_IASLC_Singapore2023.pdfKshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdf
Oleg Kshivets279 views
Kshivets_SPB_WSCTS2022Eso.pdf by Oleg Kshivets
Kshivets_SPB_WSCTS2022Eso.pdfKshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdf
Oleg Kshivets283 views
Esophageal Cancer: Precise Prediction by Oleg Kshivets
Esophageal Cancer: Precise Prediction      Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction
Oleg Kshivets98 views
Kshivets gc 10_ys_wjarr-2021-0659 by Oleg Kshivets
Kshivets gc 10_ys_wjarr-2021-0659Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659
Oleg Kshivets4.9K views
Kshivets lc10 ys_wjarr by Oleg Kshivets
Kshivets lc10 ys_wjarrKshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarr
Oleg Kshivets5.8K views
Kshivets ASCVTS Moscow2018 by Oleg Kshivets
Kshivets ASCVTS Moscow2018Kshivets ASCVTS Moscow2018
Kshivets ASCVTS Moscow2018
Oleg Kshivets9.3K views

Recently uploaded

BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx by
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docxBUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docxInkhaRina
28 views4 slides
PATIENTCOUNSELLING in.pptx by
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptxskShashi1
16 views16 slides
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences by
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesSaphnix Lifesciences
24 views11 slides
Depression PPT template by
Depression PPT templateDepression PPT template
Depression PPT templateEmanMegahed6
18 views36 slides
Preparation and Evaluation Ointment.pptx by
Preparation and Evaluation Ointment.pptxPreparation and Evaluation Ointment.pptx
Preparation and Evaluation Ointment.pptxSudhanshu Sagar
51 views23 slides
Torque in orthodontics.docx by
Torque in orthodontics.docxTorque in orthodontics.docx
Torque in orthodontics.docxDr.Mohammed Alruby
8 views17 slides

Recently uploaded(20)

BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx by InkhaRina
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docxBUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
InkhaRina28 views
PATIENTCOUNSELLING in.pptx by skShashi1
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi116 views
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences by Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Depression PPT template by EmanMegahed6
Depression PPT templateDepression PPT template
Depression PPT template
EmanMegahed618 views
Preparation and Evaluation Ointment.pptx by Sudhanshu Sagar
Preparation and Evaluation Ointment.pptxPreparation and Evaluation Ointment.pptx
Preparation and Evaluation Ointment.pptx
Sudhanshu Sagar51 views
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... by PeerVoice
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
PeerVoice8 views
STR-324.pdf by phbordeau
STR-324.pdfSTR-324.pdf
STR-324.pdf
phbordeau13 views
Referral-system_April-2023.pdf by manali9054
Referral-system_April-2023.pdfReferral-system_April-2023.pdf
Referral-system_April-2023.pdf
manali905437 views
Pregnancy tips.pptx by reachout7
Pregnancy tips.pptxPregnancy tips.pptx
Pregnancy tips.pptx
reachout736 views
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences by Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix LifesciencesPharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Basic Life support (BLS) workshop presentation. by Dr Sanket Nandekar
Basic Life support (BLS) workshop presentation.Basic Life support (BLS) workshop presentation.
Basic Life support (BLS) workshop presentation.
Lifestyle Measures to Prevent Brain Diseases.pptx by Sudhir Kumar
Lifestyle Measures to Prevent Brain Diseases.pptxLifestyle Measures to Prevent Brain Diseases.pptx
Lifestyle Measures to Prevent Brain Diseases.pptx
Sudhir Kumar618 views
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... by PeerVoice
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
PeerVoice7 views

Kshivets IASLC 2019

  • 1. Early Detection of Lung Cancer: Optimal Strategies Oleg Kshivets, MD, PhD Surgery Department, Roshal Hospital, Roshal, Moscow, Russia Objective: Significance of blood cell subpopulations in terms of early detection of lung cancer (LC) was investigated. Methods: In trial (1987-2019) consecutive cases after surgery, monitored 115 LC patients (LCP) (m=100, f=15; lobectomies=115) with pathologic stage IA (tumor size=1.86±0.30 cm; squamous=51, adenocarcinoma=59, large cell=5; T1N0M0=115; G1=39, G2=42, G3=34, 5-year survival=100%) and control group (CG) (n=402): 120 healthy donors (HD) (m=69, f=51) and 282 patients with lung non-malignant pathology (NMP) (m=188, f=94; pneumonectomies=5, lobectomies=179, segmentectomies=98; non-malignant tumors=100; abscess=112; tuberculoma=70) were reviewed. Variables selected for study were input levels of blood cell circuit, sex, age, TNMG. Differences between groups were evaluated using discriminant analysis, clustering, nonlinear estimation, structural equation modeling, Monte Carlo, bootstrap simulation and neural networks computing. Results: It was revealed that early detection of LC from CG (n=517) significantly depended on: leucocytes (abs, total), segmented neutrophils (%, abs, total), lymphocytes (%), monocytes (%, abs, total) (P=0.048-0.000). Neural networks computing, genetic algorithm selection and bootstrap simulation revealed relationships of early detection of LC and lymphocytes (rank=1), segmented neutrophils (rank=2), monocytes (3), eosinophils (4), leucocytes (5), stick neutrophils (6). Correct recognition of early LCP from CG was 100% by neural networks computing (error=0.000; area under ROC curve=1.0). Conclusion: Early detection of LC from HD and NMP significantly depended on blood cell subpopulations. Blood Factors Mean NMP+Norm Mean Cancer t-value p Std.Dev. NMP+Norm Std.Dev. Cancer Leucocytes 5.32015 5.87043 -2.71185 0.006915 1.78399 2.33204 Stick Neutrophils 0.99502 1.09565 -0.64469 0.519414 1.50973 1.35059 Segmented Neutrophils 58.39055 61.46087 -2.53241 0.011624 11.55100 11.15622 Eosinophils 3.56219 3.05617 1.37675 0.169188 3.71119 2.47445 Monocytes 2.94527 3.46087 -1.97725 0.048546 2.32024 2.92085 Lymphocytes 34.19403 30.94783 2.75936 0.005998 11.23262 10.73594 Eosinophils abs 0.18837 0.17902 0.43436 0.664208 0.21370 0.16201 Stick Neutrophils abs 0.05749 0.07092 -1.09385 0.274532 0.11302 0.12631 Segmented Neutrophils abs 3.14426 3.60482 -3.10649 0.001998 1.36638 1.52038 Lymphocytes abs 1.77649 1.80523 -0.30561 0.760026 0.77289 1.21320 Monocytes abs 0.15535 0.21188 -3.36648 0.000818 0.13944 0.21328 Eosinophils tot 0.91769 0.86378 0.51673 0.605569 1.03943 0.77206 Stick Neutrophils tot 0.27943 0.35086 -1.22613 0.220709 0.52941 0.62059 Segmented Neutrophils tot 15.30056 17.73777 -3.16338 0.001652 7.03675 8.09992 Lymphocytes tot 8.62168 8.80075 -0.37016 0.711413 4.09357 5.96624 Monocytes tot 0.75284 1.04564 -3.55172 0.000418 0.68479 1.04679 Leucocytes tot 25.85628 28.79386 -2.68146 0.007565 9.74573 12.27662 Blood Factors N=517 Discriminant Function Analysis Summary (elc_dp_n002) No. of vars in model: 17; Grouping: Ca_NMP (2 grps) Wilks' Lambda: .93942 approx. F (17,499)=1.8928 p< .0166 Wilks' Lambda Partial Lambda F-remove (1,499) p-value Toler. 1-Toler. (R-Sqr.) Leucocytes 0.945636 0.993430 3.299895 0.069884 0.000030 0.999970 Stick Neutrophils 0.941472 0.997824 1.088048 0.297409 0.108486 0.891514 Segmented Neutrophils 0.941266 0.998043 0.978654 0.323011 0.004721 0.995279 Eosinophils 0.944501 0.994624 2.697189 0.101155 0.031829 0.968171 Monocytes 0.944698 0.994417 2.801764 0.094787 0.048493 0.951507 Lymphocytes 0.942826 0.996391 1.807346 0.179438 0.004708 0.995292 Eosinophils abs 0.948309 0.990630 4.719812 0.030287 0.002269 0.997731 Stick Neutrophils abs 0.944118 0.995028 2.493570 0.114946 0.004633 0.995367 Segmented Neutrophils abs 0.945233 0.993854 3.085688 0.079597 0.000056 0.999944 Lymphocytes abs 0.946093 0.992951 3.542417 0.060400 0.000137 0.999864 Monocytes abs 0.944160 0.994983 2.515877 0.113338 0.003474 0.996526 Eosinophils tot 0.947924 0.991032 4.515480 0.034080 0.002778 0.997222 Stick Neutrophils tot 0.943604 0.995569 2.220710 0.136802 0.005169 0.994831 Segmented Neutrophils tot 0.945435 0.993641 3.193357 0.074545 0.000057 0.999943 Lymphocytes tot 0.946065 0.992980 3.527546 0.060940 0.000143 0.999857 Monocytes tot 0.941900 0.997370 1.315639 0.251926 0.003925 0.996075 Leucocytes tot 0.945715 0.993347 3.341892 0.068134 0.000028 0.999972 Effect All Groups Ca—NMP+Norm - Test of all effects Distribution : BINOMIAL, Link function: LOGIT Modeled probability that Ca—NMP+Norm=Ca Degr. of Freedom Wald Stat. p Intercept 1 2.770466 0.096018 Leucocytes 1 4.424666 0.035423 Stick Neutrophils 1 2.169120 0.140807 Segmented Neutrophils 1 2.539519 0.111029 Eosinophils 1 5.206370 0.022504 Monocytes 1 3.465356 0.062667 Lymphocytes 1 3.564749 0.059019 Eosinophils abs 1 5.786612 0.016149 Stick Neutrophils abs 1 4.212904 0.040118 Segmented Neutrophils abs 1 4.277158 0.038628 Lymphocytes abs 1 4.608960 0.031805 Monocytes abs 1 3.934539 0.047304 Eosinophils tot 1 5.587765 0.018086 Stik Neutrophils tot 1 4.061129 0.043881 Segmented Neutrophils tot 1 4.379579 0.036372 Lymphocytes tot 1 4.621466 0.031574 Monocytes tot 1 3.281245 0.070076 Leucocytes tot 1 4.482998 0.034234 Neural Networks: n=517; Baseline Error=0.000; Area under ROC Curve=1.000; Correct Classification Rate=100% Rank Sensitivity Lymphocytes 1 211222 Segmented Neutrophils 2 16605 Monocytes 3 11174 Eosinophils 4 9421 Leucocytes 5 9065 Stick Neutrophils 6 8777 Bootstrap Simulation Significant Factors (Number of Samples=3333) Rank Kendall’Tau-A P< Segmented Neutrophils abs 1 -0.075 0.05 Segmented Neutrophils tot 2 -0.069 0.05 Lymphocytes 3 0.063 0.05 Leucocytes tot 4 -0.059 0.05 P132